Peritoneal Serous Carcinoma

• CLINICAL_TRIALS withdrawal · 2025-05-13
  Clinical Trial Update: Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) [Phase 1, Phase 2]

  Clinical trial update indicates the Phase 1/2 study of birinapant in combination with carboplatin for recurrent high-grade ovarian, fallopia…

• CLINICAL_TRIALS trial_result · 2020-09-29
  Clinical Trial Update: Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer [Phase 2, Phase 3]

  Clinical trial update on trametinib for recurrent or progressive low-grade ovarian cancer and peritoneal serous cancers (Phase 2/Phase 3) wi…

• CLINICAL_TRIALS research · 2017-08-22
  Clinical Trial Update: French National Registry of Rare Peritoneal Surface Malignancies

  An update on the French National Registry of Rare Peritoneal Surface Malignancies (NCT02834169) detailing conditions affecting peritoneal su…